SGLT2 inhibitors for diabetes are safe for older adults

20 Dec 2019


According to a new study presented at the International Diabetes Federation (IDF) Congress 2019, SGLT2 inhibitors for the treatment of diabetes are safe and effective for older adults.

Medscape


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story